Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

Bridging Therapy's effects on clinical outcomes after commercial BCMA CAR T-cell therapy used in the standard of care treatment of relapsed and refractory multiple myeloma

Kimberly Burcher, Amber Feng, Terrell Coring, Taylor Addis, Emily Sellars, Melissa Martin, Tanya Bellavia, Lauren Jones, Daniel Schrum, Erin Eberwein, Erin Kennedy, Cristina Gasparetto, Cristiana Costa Chase, Taewoong Choi, Sendhilnathan Ramalingam, Gwynn Long, Suzanne Kirby, Chenyu Lin, Yubin Kang

Blood (2025) 146 (Supplement 1): 6379.

https://doi.org/10.1182/blood-2025-6379

Published: 2025

Journal Articles

RXR agonist IRX4204 induces ferroptosis in multiple myeloma via HMOX1/GPX4 axis and enhances lenalidomide efficacy

Jian Wu, Zhibo Yan, Kimberly Burcher, Zhannan Han, Mikhail Nikiforov, Vidyasagar Vuligonda, Martin Sanders, Yubin Kang

Blood (2025) 146 (Supplement 1): 3950.

https://doi.org/10.1182/blood-2025-3950

Published: 2025

Journal Articles

RXR agonist IRX4204 enhances BCMA CAR-T-cell efficacy by suppressing ferroptosis via CHAC1 downregulation

Jian Wu, Ying Zhou, Kimberly Burcher, Louisa Wirthlin, Jen Makepeace, Pamela Noldner, Pradyot Dash, Mikhail Nikiforov, Beth Shaz, Vidyasagar Vuligonda, Martin Sanders, Yubin Kang

Blood (2025) 146 (Supplement 1): 3947.

https://doi.org/10.1182/blood-2025-3947

Published: 2025